| Droperidol Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Droperidol 2.5 mg/mL | solution | injectable | 1.0 milliliter(s) | OTC |
| Droperidol - | powder | compounding | 100.0 gram(s) | OTC |
ProStrakan Reports Further Strong Progress in Pre- - PharmiWeb.com (press release)
Strong growth in recently launched pan-European products (Tostran, Rectogesic & Droperidol) with sales up 45%. • NDA for Sancuso under review by FDA, ...
Mon Jan 14 09:05:26 -0500 2008
ProStrakan Group plc - Trading Update - Reuters
Strong growth in recently launched pan-European products (Tostran, Rectogesic & Droperidol) with sales up 45%. ? Continuing improvement in gross margins. ...
Tue Jan 08 03:02:02 -0500 2008
ProStrakan Group plc - Trading Update - Reuters
Strong growth in recently launched pan-European products (Tostran, Rectogesic & Droperidol) with sales up 45%. ? Continuing improvement in gross margins. ...
Tue Jan 08 03:02:02 -0500 2008
droperidol - A butyrophenone with anti-emetic, sedative and anti-anxiety properties. Although the exact mechanism through which droperidol exerts its effects is unknown, droperidol may block dopamine receptors in the chemoreceptor trigger zone (CTZ), which may lead to its anti-emetic effect. This agent may also bind to postsynaptic gamma-aminobutyric acid (GABA) receptors in the central nervous system (CNS), which increases the inhibitory effect of GABA and leads to sedative and anti-anxiety activities.